0000950170-24-025878.txt : 20240305
0000950170-24-025878.hdr.sgml : 20240305
20240305160613
ACCESSION NUMBER: 0000950170-24-025878
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240302
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Marvin L
CENTRAL INDEX KEY: 0001493324
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 24720295
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
ownership.xml
4
X0508
4
2024-03-02
0001671584
Aptevo Therapeutics Inc.
APVO
0001493324
White Marvin L
2401 4TH AVENUE
1050
SEATTLE
WA
98121
true
true
false
false
President and CEO
false
Common Stock
2024-03-02
4
M
false
12917
A
57846
D
Common Stock
2024-03-03
4
M
false
9584
A
67430
D
Restricted Stock Unit
2024-03-02
4
M
false
12917
0
D
Common Stock
12917
25833
D
Restricted Stock Unit
2024-03-03
4
M
false
9584
0
D
Common Stock
9584
9584
D
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
On March 3, 2023, the reporting person was granted 38,750 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
On June 7, 2022, the reporting person was granted 28,750 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.
/s/ SoYoung Kwon, Attorney-in-Fact
2024-03-05